| 國立臺灣大學 |
2013 |
Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non-Small-Cell Lung Cancer
|
Liao, Wei-Yu; Chen, Jin-Hsin; Wu, Muzo; Shih, Jin-Yuan; Chen, Kuan-Yuh; Ho, Chao-Chi; Yang, James Chih-Hsin; Yu, Chong-Jen; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 施金元 |
| 臺大學術典藏 |
2020-05-26T09:27:02Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Liao W.-Y;Chen J.-H;Wu M;Shih J.-Y;Chen K.-Y;Ho C.-C;Chih-Hsin Yang;Yu C.-J.; Liao W.-Y; Chen J.-H; Wu M; Shih J.-Y; Chen K.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:29Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Chen K.-Y.; Wu M.; Shih J.-Y.; Chen J.-H.; Liao W.-Y.; CHAO-CHI HO; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:47Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Yang J.C.-H.; Ho C.-C.; Chen K.-Y.; JIN-YUAN SHIH; Wu M.; Chen J.-H.; Liao W.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Wei-Yu Liao;Chen J.-H.;Wu M.;Shih J.-Y.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Yu C.-J.; WEI-YU LIAO; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-04-29T02:38:38Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Anonymous |
| 臺大學術典藏 |
2021-04-29T05:09:07Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Liao W.-Y.; Chen J.-H.; Wu M.; Shih J.-Y.; KUAN-YU CHEN; Ho C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-06-27T07:01:58Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Liao W.-Y.; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; CHONG-JEN YU |
| 國家衛生研究院 |
2025-07 |
Neoadjuvant immunotherapy is associated with a recurrence free survival benefit versus active surveillance in patients with resected hepatocellular cancer
|
Brunetti, L;D'Alessio, A;Fulgenzi, CAM;Yarchoan, M;Marron, T;Blanter, J;Torkpour, A;Lombardi, P;Baretti, M;Crowley, F;Hsu, C;Cortellini, A;Su, YY;Lee, PC;Eid, JR;Kaseb, A;Pinato, DJ |
| 臺北醫學大學 |
2006 |
Neoadjuvant Leuplin treatment reduces the operation time and blood loss and pelvic adhesion of laparoscopic enucleation of endometriomas
|
曾啟瑞; Chen PH; Chuang CC; Chen D; Hsu HC; Tzeng CR; |
| 國立成功大學 |
2023 |
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study
|
Tsai, J.-H.;Li, C.-L.;Yeh, D.-C.;Hung, C.-S.;Hung, C.-C.;Lin, C.-Y.;Kuo, Y.-L. |
| 臺大學術典藏 |
2022-09-21T01:28:22Z |
Neoadjuvant Stereotactic Body Radiation Therapy for Spine Metastases
|
Chun Lin, Pao; Ming Hsu, Feng; Chen, Yi Hsing; FU-REN XIAO |
| 臺大學術典藏 |
2019 |
Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study
|
Slamon D.; Thompson A.M.; Fraser Symmans W.; Hurvitz S.A.;Martin M.;Jung K.H.;Chiun-Sheng Huang;Harbeck N.;Valero V.;Stroyakovskiy D.;Wildiers H.;Campone M.;Boileau J.-F.;Fasching P.A.;Afenjar K.;Spera G.;Lopez-Valverde V.;Song C.;Trask P.;Boulet T.;Sparano J.A.;Fraser Symmans W.;Thompson A.M.;Slamon D.; Hurvitz S.A.; Martin M.; Jung K.H.; CHIUN-SHENG HUANG; Harbeck N.; Valero V.; Stroyakovskiy D.; Wildiers H.; Campone M.; Boileau J.-F.; Fasching P.A.; Afenjar K.; Spera G.; Lopez-Valverde V.; Sparano J.A.; Boulet T.; Trask P.; Song C. |
| 臺大學術典藏 |
2018-09-10T18:05:39Z |
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
|
Martin, M.; Symmans, W.F.; Jung, K.H.; Huang, C.-S.; Thompson, A.M.; Harbeck, N.; Valero, V.; Stroyakovskiy, D.; Wildiers, H.; Campone, M.; Boileau, J.-F.; Beckmann, M.W.; Afenjar, K.; Fresco, R.; Helms, H.-J.; Xu, J.; Lin, Y.G.; Sparano, J.; Slamon, D.; Hurvitz, S.A.; CHIUN-SHENG HUANGet al. |
| 臺大學術典藏 |
2020-03-23T07:18:55Z |
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
|
Fresco R.; Helms H.-J.; Xu J.; Lin Y.G.; Sparano J.; Slamon D.; Beckmann M.W.; Afenjar K.; Campone M.; Boileau J.-F.; Wildiers H.; Stroyakovskiy D.; Harbeck N.; Valero V.; Thompson A.M.; CHIUN-SHENG HUANG; Jung K.H.; Symmans W.F.; Martin M.; Hurvitz S.A.; Hurvitz S.A.;Martin M.;Symmans W.F.;Jung K.H.;Chiun-Sheng Huang;Thompson A.M.;Harbeck N.;Valero V.;Stroyakovskiy D.;Wildiers H.;Campone M.;Boileau J.-F.;Beckmann M.W.;Afenjar K.;Fresco R.;Helms H.-J.;Xu J.;Lin Y.G.;Sparano J.;Slamon D. |
| 中山醫學大學 |
2020 |
Neoadjuvant Versus Definitive Concurrent Chemoradiotherapy In Stage III Esophageal Cancer Patients
|
Chen, HL; Chou, YH; Lee, Y; Tseng, HC |
| 國立成功大學 |
2024-06-1 |
Neoadjuvant/adjuvant pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo for gastric/gastroesophageal junction (G/GEJ) adenocarcinoma: Major pathologic response (mPR) in KEYNOTE-585
|
Shitara;Kohei;Bang;Yung-Jue;Wyrwicz;Lucjan, S.;Rha;Young, Sun;Oshima;Takashi;Bartolomeo, Di;Maria;Park;Young-Kyu;Lonardi;Sara;Weber;Yanez, Patricio Eduardo;Yen;Chia-Jui;Metges;Jean-Philippe;Garrido;Marcelo;Moehler;Markus, H.;Pelles-Avraham;Sharon;Yong;Wei-Peng;Spallanzani;Andrea;Jensen;Erin;Krishnan;Radha;Shih;Chie-Schin;Al-Batran;Salah-Eddin |
| 中國醫藥大學 |
2001-04 |
Neoadjuvent chemotherapy and breast conserving surgery
|
張嘉麟 |
| 衛生福利部國家中醫藥研究所 |
2012-04-15 |
Neobavaisoflavone stimulates osteogenesis via p38-mediated up-regulation of transcription factors and osteoid genes expression in MC3T3-E1 cells
|
Don, Ming-Jaw;Lin, Lie-Chwen;Chiou, Wen-Fei |
| 國立臺灣大學 |
2006 |
Neobenedenia girellae (Monogenea) Infection of Cultured Cobia Rachycentron canadum in Taiwan
|
Ogawa, Kazuo; Miyamoto, Junko; Wang, Han-Ching; Lo, Chu-Fang; Kou, Guang-Hsiung |
| 國立臺灣大學 |
2006-06 |
Neobenedenia girellae (Monogenea) infection of cultured cobia Rachycentron canadum in Taiwan.
|
Ogawa K; Miyamoto J; Wang HC; Lo CF; Kou GH |
| 國立成功大學 |
2019-01-15 |
Neocaridina fonticulata, a new land-locked freshwater shrimp from Hengchun Peninsula, Taiwan (Decapoda, Caridea, Atyidae)
|
Shih;Hsi-Te;Cai;Yixiong;Chiu;Yuh-Wen |
| 國家衛生研究院 |
2013-12 |
Neocartilage formation from mesenchymal stem cells grown in type II collagen-hyaluronan composite scaffolds
|
Yeh, HY;Lin, TY;Lin, CH;Yen, BL;Tsai, CL;Hsu, SH |
| 臺大學術典藏 |
2018-09-10T09:43:00Z |
Neocartilage formation from mesenchymal stem cells grown in type II collagen-hyaluronan composite scaffolds
|
Lin, C.-H.; Yen, B.L.; Tsai, C.-L.; Hsu, S.-H.; SHAN-HUI HSU; SHAN-HUI HSU;Hsu, S.-H.;Tsai, C.-L.;Yen, B.L.;Lin, C.-H.;Lin, T.-Y.;Yeh, H.-Y.;SHAN-HUI HSU; Yeh, H.-Y.; Lin, T.-Y. |
| 國立臺灣大學 |
1992 |
Neocaryachine, a New Pavine Alkaloid Form Cryptocarya Chinensis, and NMR Spectral Properties of Related Alkaloids
|
李水盛; Liu, Yi-Chu; Chen, Hung-Hsiung; Lee, Shoei-Sheng; Liu, Yi-Chu; Chen, Hung-Hsiung |
| 臺大學術典藏 |
2018-09-10T03:31:26Z |
Neocaryachine, a new pavine alkaloid from cryptocarya chinensis, and nmr spectral properties of related alkaloids
|
Lee, S.-S.;Liu, Y.-C.;Chen, C.-H.; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2021-07-16T06:18:48Z |
Neocaryachine, a new pavine alkaloid from cryptocarya chinensis, and nmr spectral properties of related alkaloids
|
SHOEI-SHENG LEE; Liu Y.-C.; Chen C.-H. |
| 中國醫藥大學 |
2011 |
Neocarzinostatin as a probe for DNA PROTECTION ACTIVITY-Molecular interaction with caffeine
|
(Der-Hang Chin)*; (Huang-Hsien Li); 郭秀滿; 李珮端(Pei Dawn Lee Chao); (Chia-Wen Liu) |
| 高雄醫學大學 |
2002 |
Neocarzinostatin 導致 Mrell 磷酸化和集中形成經由ATM及NBS1獨立機轉
|
袁行修;張秀玲;侯明鋒;詹德富;高音信;吳永昌;蘇鈞煌 ; Shyng-Shiou F. Yuan;Hsueh-Ling Chang;Ming-Feng Hou;Te-Fu Chan;Ying-Hsien Kao;Yang-Chang Wu;Jinu-Huang Su |
| 中山醫學大學 |
2021 |
Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro
|
Yu, MH; Hung, TW; Wang, CC; Wu, SW; Yang, TW; Yang, CY; Tseng, TH; Wang, CJ |
| 中山醫學大學 |
2021-12 |
Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro
|
Yu, Meng-Hsun;Hung, Tung-Wei;Wang, Chi-Chih;Wu, Sheng-Wen;Yang, Tzu-Wei;Yang, Ching-Yu;Tseng, Tsui-Hwa;Wang, Chau-Jong |
| 中山醫學大學 |
2021-12 |
Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro
|
Yu, Meng-Hsun;Hung, Tung-Wei;Wang, Chi-Chih;Wu, Sheng-Wen;Yang, Tzu-Wei;Yang, Ching-Yu;Tseng, Tsui-Hwa;Wang, Chau-Jong |
| 國立東華大學 |
2003-04 |
Neoclassical Bootstrap Current in High p Tokamak Plasmas
|
Lin-Liu, Y.R. |
| 國立東華大學 |
2003-04 |
Neoclassical Bootstrap Current in High p Tokamak Plasmas
|
Lin-Liu Y. R. |
| 國立成功大學 |
2004 |
Neoclassical dissipation and resistive wall modes in tokamaks
|
Shaing, Ker-Chung |
| 國立成功大學 |
1983 |
Neoclassical flows and transport in nonaxisymmetric toroidal plasmas
|
Shaing, Ker-Chung; Callen, J. D. |
| 國立成功大學 |
2018-12 |
Neoclassical quasilinear theory and universal collision frequency landscape in wave-particle interaction in tokamaks
|
Shaing;K, C. |
| 國立成功大學 |
2017-12 |
Neoclassical quasilinear theory in the superbanana plateau regime and banana kinetics in tokamaks
|
Shaing;K, C. |
| 國立成功大學 |
1988 |
Neoclassical quasilinear transport theory of fluctuations in toroidal plasmas
|
Shaing, Ker-Chung |
| 國立成功大學 |
1990 |
Neoclassical quasilinear transport theory of fluctuations in toroidal plasmas: Further considerations
|
Shaing, Ker-Chung |
| 國立成功大學 |
2012-02 |
Neoclassical theory inside transport barriers in tokamaks
|
Shaing, K. C.; Hsu, C. T. |
| 國立成功大學 |
2009-03 |
Neoclassical toroidal plasma viscosity in the low collisionality regime for tokamaks
|
Shaing, Ker-Chung; Sabbagh, S. A.; Chu, M. S. |
| 國立成功大學 |
2009-03 |
Neoclassical toroidal plasma viscosity in the superbanana plateau regime for tokamaks
|
Shaing, Ker-Chung; Sabbagh, S. A.; Chu, M. S. |
| 國立成功大學 |
2009-05 |
Neoclassical toroidal plasma viscosity in the superbanana regime in tokamaks
|
Shaing, Ker-Chung; Sabbagh, S. A.; Chu, M. S. |
| 國立成功大學 |
2015-08 |
Neoclassical toroidal plasma viscosity in the vicinity of the magnetic axis in tokamaks with broken symmetry
|
Shaing, K. C.; Lee, H.; Seol, J.; Aydemir, A. Y. |
| 國立成功大學 |
2016-07 |
Neoclassical toroidal plasma viscosity with effects of finite banana width for finite aspect ratio tokamaks
|
Shaing, K. C.; Sabbagh, S. A. |
| 國立成功大學 |
1986 |
Neoclassical transport fluxes in the plateau regime in nonsymmetric toroidal plasmas,
|
Shaing, Ker-Chung; Hirshman, S. P.; Callen, J. D. |
| 國立成功大學 |
1983 |
Neoclassical transport in a multiple-helicity torsatron in the low-collisionality (1/ν) regime
|
Shaing, Ker-Chung; Hokin, S. A. |
| 國立成功大學 |
2007 |
Neoclassical troidal viscosity for an axisymmetric toroidal equilibrium with mutiple trapping of particles
|
Shaing, Ker-Chung; Sabbagh, S. A.; Peng, M. |
| 南台科技大學 |
2005-02 |
Neoclerodane Diterpenoids from Ajuga taiwanensis
|
詹于誼; Yu-Yi Chan |
